These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32792303)

  • 1. Successful Treatment of Primary Refractory Angioimmunoblastic T-cell Lymphoma With Cord Blood Transplantation.
    Ichikawa S; Fukuhara N; Saito K; Furukawa E; Onodera K; Onishi Y; Yokoyama H; Ichinohasama R; Harigae H
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e926-e929. PubMed ID: 32792303
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma.
    Sumi M; Takeda W; Kaiume H; Kirihara T; Kurihara T; Sato K; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Kobayashi H
    Leuk Lymphoma; 2015 Apr; 56(4):1140-2. PubMed ID: 25065703
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis.
    Epperla N; Ahn KW; Litovich C; Ahmed S; Battiwalla M; Cohen JB; Dahi P; Farhadfar N; Farooq U; Freytes CO; Ghosh N; Haverkos B; Herrera A; Hertzberg M; Hildebrandt G; Inwards D; Kharfan-Dabaja MA; Khimani F; Lazarus H; Lazaryan A; Lekakis L; Murthy H; Nathan S; Nishihori T; Pawarode A; Prestidge T; Ramakrishnan P; Rezvani AR; Romee R; Shah NN; Sureda A; Fenske TS; Hamadani M
    J Hematol Oncol; 2019 Jan; 12(1):6. PubMed ID: 30630534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained Remission of γδ T-Cell Lymphoma by Graft-Versus-Lymphoma Effect That Relapsed Early After Cord Blood Transplantation.
    Ichikawa S; Fukuhara N; Onishi Y; Ichinohasama R; Harigae H
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):e369-e372. PubMed ID: 30017597
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of advanced extranodal NK/T cell lymphoma with unrelated cord blood transplantation.
    Yokoyama H; Yamada MF; Ishizawa K; Yamamoto J; Tomiya Y; Harigae H; Kameoka J; Ichinohasama R; Sasaki T
    Tohoku J Exp Med; 2007 Apr; 211(4):395-9. PubMed ID: 17409680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of cord blood transplantation for the treatment of refractory angioimmunoblastic T-cell lymphoma: a series of three cases.
    Kazuma Y; Shimazu Y; Hishizawa M; Nishikori M; Kitano T; Kondo T; Yamashita K; Takaori-Kondo A
    Bone Marrow Transplant; 2019 Oct; 54(10):1710-1712. PubMed ID: 30809041
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical outcomes of hematopoietic stem cell transplantation for angioimmunoblastic T-cell lymphoma].
    Xu LM; Li NN; Wang Z; Wu XX; Dong YJ; Fu XR; Liu Y; Hu LD; Li XF; Wang YN; Wu YM; Ren HY; Zhang MZ; Wang MH; Li YH; Huang WR
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):573-577. PubMed ID: 32397020
    [No Abstract]   [Full Text] [Related]  

  • 8. Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseases.
    Sawada A; Inoue M; Koyama-Sato M; Kondo O; Yamada K; Shimizu M; Isaka K; Kimoto T; Kikuchi H; Tokimasa S; Yasui M; Kawa K
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):214-21. PubMed ID: 24188918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of Epstein-Barr virus-specific antigen peptide-activated cytotoxic T-cells treatment for refractory or recurrent angioimmunoblastic T-cell lymphoma: A prospective clinical observational study.
    Bingjie W; Lihong W; Yongjin S; Huihui L; Jinping O; Xi'nan C
    Hematol Oncol; 2020 Aug; 38(3):272-276. PubMed ID: 32083758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epstein-Barr virus-related B-cell lymphoma of the skin which developed early after cord blood transplantation for angioimmunoblastic T-cell lymphoma].
    Tajika K; Tamai H; Mizuki T; Nakayama K; Yamaguchi H; Dan K
    Rinsho Ketsueki; 2010 Feb; 51(2):138-42. PubMed ID: 20379106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful rituximab treatment of an EBV-related lymphoproliferative disease arising after autologous transplantation for angioimmunoblastic T-cell lymphoma.
    Park S; Noguera ME; Brière J; Feuillard J; Cayuela JM; Sigaux F; Brice P
    Hematol J; 2002; 3(6):317-20. PubMed ID: 12522456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with mogamulizumab of refractory/relapsed angioimmunoblastic T-cell lymphoma following autologous stem cell transplantation.
    Oka S; Ono K; Nohgawa M
    Leuk Lymphoma; 2019 Jun; 60(6):1595-1597. PubMed ID: 30732495
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful reduced-intensity stem cell transplantation with cord blood for a poor-prognosis adult with refractory chronic active epstein-barr virus infection.
    Nakagawa M; Hashino S; Takahata M; Kawamura T; Fujisawa F; Kahata K; Kondo T; Imamura M; Ando S; Asaka M;
    Int J Hematol; 2007 Jun; 85(5):443-5. PubMed ID: 17562623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
    Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic transplantation in T-cell lymphomas.
    Schmitz N; Wu HS; Glass B
    Semin Hematol; 2014 Jan; 51(1):67-72. PubMed ID: 24468318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
    Le Gouill S; Milpied N; Buzyn A; De Latour RP; Vernant JP; Mohty M; Moles MP; Bouabdallah K; Bulabois CE; Dupuis J; Rio B; Gratecos N; Yakoub-Agha I; Attal M; Tournilhac O; Decaudin D; Bourhis JH; Blaise D; Volteau C; Michallet M;
    J Clin Oncol; 2008 May; 26(14):2264-71. PubMed ID: 18390969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Cord Blood Stem Cell Transplantation for an Adult Case of Chronic Active Epstein-Barr Virus Infection.
    Saburi M; Ogata M; Satou T; Yoshida N; Nagamatsu K; Nashimoto Y; Moroga Y; Takano K; Kohno K; Shirao K
    Intern Med; 2016; 55(23):3499-3504. PubMed ID: 27904117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma.
    Matsunaga T; Murase K; Yoshida M; Fujimi A; Iyama S; Kuribayashi K; Sato T; Kogawa K; Hirayama Y; Sakamaki S; Kohda K; Niitsu Y
    Am J Hematol; 2005 Aug; 79(4):294-8. PubMed ID: 16044441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas.
    Schmitz N; Lenz G; Stelljes M
    Blood; 2018 Jul; 132(3):245-253. PubMed ID: 29699989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.